UC Davis Cohort of Pre-Malignant and Malignant Gastro-Intestinal DisEases Study

Part of paid clinical trials in Sacramento, California.

Sponsor
University of California, Davis
Study ID
NCT05021029
Status
Enrolling By Invitation

Conditions

  • Atrophic Gastritis
  • Autoimmune Gastritis
  • Chronic Gastritis
  • Gastric Polyps
  • Intestinal Dysplasia
  • Intestinal Metaplasia

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The UC Davis Cohort of Pre-Malignant and Malignant GastroIntestinal DisEases (TUMMIE) Study is a prospective longitudinal cohort study designed to improve understanding of the natural history, risk factors, and biological mechanisms underlying gastric pre-malignant conditions and progression to gastric cancer. The study will enroll up to 1,000 adults diagnosed with chronic gastritis, atrophic gastritis, autoimmune gastritis, gastric intestinal metaplasia, gastric dysplasia, or gastric polyps and follow participants for at least five years.

Key Dates

First listed
Aug 25, 2021
Start date
Jul 13, 2021
Status verified
Aug 2026
Primary completion
Oct 31, 2030
Completion
Oct 31, 2030

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Pre-malignant progression [ Time Frame: Baseline, and yearly for 5 years. ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of California Davis Comprehensive Cancer CenterSacramentoCalifornia95817-

Find similar trials in Sacramento, CA

By research site
University of California Davis Comprehensive Cancer Center· Sacramento, CA

Related Studies